GLS and neoplasm: For instance, when GLS inhibitors (e.g., CB-839) are combined with immune checkpoint inhibitors, tumor cells may activate alternative metabolic routes, such as the glutamine synthesis pathway, to circumvent the metabolic stress induced by GLS inhibition (336, 337).